77 related articles for article (PubMed ID: 17024043)
1. Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.
Schilling MM; Oeser JK; Boustead JN; Flemming BP; O'Brien RM
Nature; 2006 Oct; 443(7111):E10-1. PubMed ID: 17024043
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-alpha attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells.
Pandey AK; Bhardwaj V; Datta M
FEBS J; 2009 Jul; 276(14):3757-69. PubMed ID: 19769745
[TBL] [Abstract][Full Text] [Related]
3. GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1.
Sakamaki J; Daitoku H; Kaneko Y; Hagiwara A; Ueno K; Fukamizu A
J Recept Signal Transduct Res; 2012 Apr; 32(2):96-101. PubMed ID: 22384829
[TBL] [Abstract][Full Text] [Related]
4. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.
Puigserver P; Rhee J; Donovan J; Walkey CJ; Yoon JC; Oriente F; Kitamura Y; Altomonte J; Dong H; Accili D; Spiegelman BM
Nature; 2003 May; 423(6939):550-5. PubMed ID: 12754525
[TBL] [Abstract][Full Text] [Related]
5. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.
Shlomai A; Rechtman MM; Burdelova EO; Zilberberg A; Hoffman S; Solar I; Fishman S; Halpern Z; Sklan EH
J Hepatol; 2012 Oct; 57(4):867-73. PubMed ID: 22732512
[TBL] [Abstract][Full Text] [Related]
6. Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis.
Chen J; Zhang Z; Wang N; Guo M; Chi X; Pan Y; Jiang J; Niu J; Ksimu S; Li JZ; Chen X; Wang Q
Sci Rep; 2017 Jul; 7(1):6102. PubMed ID: 28733598
[TBL] [Abstract][Full Text] [Related]
7. Acute exercise modulates the Foxo1/PGC-1alpha pathway in the liver of diet-induced obesity rats.
Ropelle ER; Pauli JR; Cintra DE; Frederico MJ; de Pinho RA; Velloso LA; De Souza CT
J Physiol; 2009 May; 587(Pt 9):2069-76. PubMed ID: 19273580
[TBL] [Abstract][Full Text] [Related]
8. Fasting induced up-regulation of activating transcription factor 5 in mouse liver.
Shimizu YI; Morita M; Ohmi A; Aoyagi S; Ebihara H; Tonaki D; Horino Y; Iijima M; Hirose H; Takahashi S; Takahashi Y
Life Sci; 2009 Jun; 84(25-26):894-902. PubMed ID: 19376136
[TBL] [Abstract][Full Text] [Related]
9. Mapping MKP-3/FOXO1 interaction and evaluating the effect on gluconeogenesis.
Jiao P; Feng B; Xu H
PLoS One; 2012; 7(7):e41168. PubMed ID: 22848439
[TBL] [Abstract][Full Text] [Related]
10. O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene.
Kuo M; Zilberfarb V; Gangneux N; Christeff N; Issad T
FEBS Lett; 2008 Mar; 582(5):829-34. PubMed ID: 18280254
[TBL] [Abstract][Full Text] [Related]
11. The cAMP-dependent protein kinase downregulates glucose-6-phosphatase expression through RORα and SRC-2 coactivator transcriptional activity.
Madsen A; Bjune JI; Bjørkhaug L; Mellgren G; Sagen JV
Mol Cell Endocrinol; 2016 Jan; 419():92-101. PubMed ID: 26455881
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.
Zhang P; Tu B; Wang H; Cao Z; Tang M; Zhang C; Gu B; Li Z; Wang L; Yang Y; Zhao Y; Wang H; Luo J; Deng CX; Gao B; Roeder RG; Zhu WG
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10684-9. PubMed ID: 25009184
[TBL] [Abstract][Full Text] [Related]
13. A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding.
Hirota K; Sakamaki J; Ishida J; Shimamoto Y; Nishihara S; Kodama N; Ohta K; Yamamoto M; Tanimoto K; Fukamizu A
J Biol Chem; 2008 Nov; 283(47):32432-41. PubMed ID: 18805788
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon?
Kuo M; Zilberfarb V; Gangneux N; Christeff N; Issad T
Biochimie; 2008 May; 90(5):679-85. PubMed ID: 18359296
[TBL] [Abstract][Full Text] [Related]
15. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression.
Kato S; Ding J; Pisck E; Jhala US; Du K
J Biol Chem; 2008 Dec; 283(51):35464-73. PubMed ID: 18815134
[TBL] [Abstract][Full Text] [Related]
16. DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression.
von Groote-Bidlingmaier F; Schmoll D; Orth HM; Joost HG; Becker W; Barthel A
Biochem Biophys Res Commun; 2003 Jan; 300(3):764-9. PubMed ID: 12507516
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures reveal a new and novel FoxO1 binding site within the human glucose-6-phosphatase catalytic subunit 1 gene promoter.
Singh P; Han EH; Endrizzi JA; O'Brien RM; Chi YI
J Struct Biol; 2017 Apr; 198(1):54-64. PubMed ID: 28223045
[TBL] [Abstract][Full Text] [Related]
18. STAT3 inhibition of gluconeogenesis is downregulated by SirT1.
Nie Y; Erion DM; Yuan Z; Dietrich M; Shulman GI; Horvath TL; Gao Q
Nat Cell Biol; 2009 Apr; 11(4):492-500. PubMed ID: 19295512
[TBL] [Abstract][Full Text] [Related]
19. A two-step pathway to resist fasting.
Kaestner KH
Cell Metab; 2008 Dec; 8(6):449-51. PubMed ID: 19041759
[TBL] [Abstract][Full Text] [Related]
20. Reply to Leithner et al.: Focus on phopshoenolpyruvate carboxykinase (PEPCK): a target of the p53-SIRT6-FoxO1 axis.
Li Z; Zhu WG
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4395. PubMed ID: 25261554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
